戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 iscuss the association of this disorder with Cowden syndrome.
2 ses cancer-susceptibility conditions such as Cowden syndrome.
3 sceptibility gene for PTEN mutation negative Cowden syndrome.
4 er has been shown to be a minor component of Cowden syndrome.
5  carcinogenesis in a genuine mouse model for Cowden syndrome.
6 PTEN (MMAC1/TEP1) are found in patients with Cowden syndrome, a familial cancer syndrome which is cha
7 n homolog gene (PTEN) mutations cause 80% of Cowden syndrome, a rare autosomal-dominant disorder (1 i
8 ns in PTEN are responsible for most cases of Cowden Syndrome, a rare familial trait characterized by
9          Here we show that, in patients with Cowden syndrome, an inherited cancer syndrome caused by
10 h PTEN, the tumor suppressor gene mutated in Cowden syndrome, an inherited multiple hamartoma syndrom
11                Germline PTEN mutations cause Cowden syndrome and a range of several different hamarto
12                 We show that cell lines from Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome pa
13 and heritable neoplasia syndromes, including Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
14 yndromes that exhibit some clinical overlap, Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome.
15 , SDHD-H50R) are associated with a subset of Cowden syndrome and Cowden syndrome-like individuals (CS
16  direction, may account for the remainder of Cowden syndrome and Cowden-like syndrome.
17  alleles of PTEN identified in patients with Cowden syndrome and show that the nonsense Pten(4-5) and
18  multiple endocrine neoplasia type 2 (MEN2), Cowden syndrome, and familial adenomatous polyposis (FAP
19 riety of diseases including lactic acidosis, Cowden Syndrome, and several cancers.
20 n subtle clinical findings that characterize Cowden Syndrome are frequently unrecognized, raising the
21 aps sex-specific neoplasia predisposition in Cowden syndrome, as well as why only a fraction of women
22 in individuals with two hamartoma syndromes: Cowden Syndrome, associated with a predisposition to bre
23 e mutations of PTEN have been shown to cause Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome and P
24 share several overlapping clinical features: Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Prot
25 hamartoma tumor syndrome" (PHTS) and include Cowden syndrome, Bannayan-Riley-Ruvalcaba syndrome, Prot
26 ehend the broad neoplastic manifestations of Cowden syndrome/Bannayan-Riley-Ruvalcaba and sporadic ca
27 TEN are associated with 80% of patients with Cowden syndrome (CS) and 60% of patients with Bannayan-R
28 d to 10q23.3, is the susceptibility gene for Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba (BRR)
29                                              Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
30 t heritable cancer syndromes, including both Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
31 PTEN, encoding a phosphatase on 10q23, cause Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
32                                              Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
33 is mutated in 85 and 65% of individuals with Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
34                Germline PTEN mutations cause Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
35                Germline PTEN mutations cause Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
36 yndromes that exhibit some clinical overlap, Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndro
37 line and somatic PTEN mutations are found in Cowden syndrome (CS) and multiple sporadic malignancies,
38                                              Cowden syndrome (CS) is a difficult-to-recognize multipl
39                                              Cowden syndrome (CS) is a rare autosomal dominant cancer
40                                              Cowden syndrome (CS) is an autosomal dominant disorder a
41                                              Cowden syndrome (CS) is an autosomal dominant disorder c
42                                              Cowden syndrome (CS) is an autosomal dominant disorder t
43                                              Cowden syndrome (CS) is an autosomal-dominant disorder c
44                                Patients with Cowden syndrome (CS) with underlying germline PTEN mutat
45 hyroid cancer is a major component cancer of Cowden syndrome (CS), a disorder typically associated wi
46  is a well-described predisposition gene for Cowden syndrome (CS), a familial cancer syndrome charact
47                                              Cowden syndrome (CS), a Mendelian autosomal-dominant dis
48 se and tensin homolog (PTEN) mutations cause Cowden syndrome (CS), associated with breast and thyroid
49         Individuals with PTEN mutations have Cowden syndrome (CS), associated with breast, thyroid, a
50         Germline PTEN mutations cause 85% of Cowden syndrome (CS), characterized by a high risk of br
51 sphatase tumor suppressor, is inactivated in Cowden syndrome (CS), characterized by high risk of brea
52 al-specificity phosphatase on 10q23.3, cause Cowden syndrome (CS), which is characterized by a high r
53 n to be a major susceptibility gene for both Cowden syndrome (CS), which is characterized by multiple
54             Germline mutations in PTEN cause Cowden syndrome (CS), which is characterized by multiple
55 ociated with the multihamartomatous disorder Cowden syndrome (CS).
56 y recognized that LDD may be associated with Cowden syndrome (CS).
57 Bannayan-Riley-Ruvalcaba syndrome (BRRS) and Cowden syndrome (CS).
58 nal hamartomatous polyps are also present in Cowden syndrome (CS; MIM 158350) and Bannayan-Zonana syn
59 Cowden syndrome features but who do not meet Cowden syndrome diagnostic criteria, have PTEN mutations
60 e syndrome, who have various combinations of Cowden syndrome features but who do not meet Cowden synd
61                                 The gene for Cowden syndrome has recently been located and it will no
62  in cancer susceptibility syndromes, such as Cowden syndrome, in which over 80% of patients have muta
63 hanisms of the pathogenesis of the subset of Cowden syndrome individuals with germ line promoter vari
64 ociated with a subset of Cowden syndrome and Cowden syndrome-like individuals (CS/CSL) and confer hig
65 ospective nested series of 123 patients with Cowden syndrome or Cowden-like syndrome and 50 unaffecte
66 IN methylation is common among patients with Cowden syndrome or Cowden-like syndrome and is associate
67                         Of 123 patients with Cowden syndrome or Cowden-like syndrome, 45 (37%; 95% co
68 cancers as part of families with and without Cowden syndrome or FAP.
69 mosome 10) are found in sporadic cancers and Cowden syndrome patients, respectively.
70 lysine mutant of PTEN, K289E associated with Cowden syndrome, retains catalytic activity but fails to
71  (BMP) have been found in rare families with Cowden syndrome, suggesting that there may be a link bet
72 erited hamartoma tumour syndromes, including Cowden syndrome, which has a high risk of breast and thy
73  in two inherited hamartoma tumor syndromes: Cowden syndrome, which has a high risk of breast, thyroi
74 N result in the dominantly inherited disease Cowden syndrome, which is characterized by multiple hama

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。